Detail akcie Phibro Animal Hlt-A online

Business Summary: Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Financial Summary: BRIEF: For the fiscal year ended 30 June 2025, Phibro Animal Health Corp revenues increased 27% to $1.3B. Net income increased from $2.4M to $48.3M. Revenues reflect Animal Health segment increase of 36% to $962.8M, Performance Products segment increase of 19% to $80.2M, United States segment increase of 27% to $739.9M, Latin America and Canada segment increase of 21% to $298.6M. Net income benefited from Foreign currency (gains) losses.